Banner Health has launched new clinical practice protocols developed with input from the University of Arizona Valley Fever Center for Excellence to help physicians more quickly diagnose and treat patients with Valley fever infections.

Donata Vercelli, MD, has been elected secretary general of the Collegium Internationale Allergologicum, a group of distinguished international physicians and scientists who study the emerging field of allergy and clinical immunology. As secretary general, Dr. Vercelli eventually will become the first female president of the organization.

As this public health crisis escalates, researchers are working fervently to better understand the disease and who is most at risk for developing it, as well as to find ways to detect it earlier and to slow or halt its progress.

As physicians begin to order an increasing number of genetic tests, a question remains: who can help patients, and sometimes providers, interpret genetic information?

NIH grant will allow Taben Hale, PhD, to study cardiac fibroblasts.

What lacks a brain but has the ability to swiftly avoid setting off our body’s intruder detectors, bringing its own blueprints into our cells to make more of itself, and in some cases, cause cancer? Human papillomavirus.

In 2013, Academy Award-winning actress Angelina Jolie wrote a now famous opinion piece for the New York Times detailing her journey involving genetic testing for breast and ovarian cancer.

Coccidioidomycosis, or “cocci” for short, is the medical term for Valley fever, an infectious disease that affects thousands of people in Arizona every year.

Noninvasive prenatal testing (NIPT), one of the newest additions in genomic testing, is a simple blood test that can tell a lot about a baby’s likelihood of having certain genetic conditions.